Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac-lintuzumab) (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Ryan, C.; Frattini, M. G.; Cicic, D.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Lymphodepletion and tumor burden govern clinical responses in patients with B-cell malignancies treated with autologous, CD19-targeted T cells
    Meeting Abstract

    Brentjens, R. J.; Riviere, I.; Park, J.; Davilla, M.; Wang, X.; Yeh, R.; Lamanna, N.; Frattini, M. G.; Sadelain, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • YK5, a small molecule inhibitor of Hsp70 and Hsc70, reveals a multifaceted role for the Hsp70 chaperones in regulating oncogenic and non-oncogenic addiction of tumors
    Meeting Abstract

    Rodina, A.; Kang, Y.; Taldone, T.; Patel, H.; Patel, P.; Caldas-Lopes, E.; Erdjument-Bromage, H.; Guzman, M.; Young, J. C.; Melnick, A.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Molecular dissection of cell death mechanisms following ionizing radiation in vitro and in vivo
    Meeting Abstract

    Welliver, M. X.; Hart, L. S.; Ye, J. B.; Lu, C.; Mick, R.; Kong, M.; Ditsworth, D.; Mesina, A.; Zhao, F. P.; Guerriero, J. L.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • FLT3-ITD+ AML blast, progenitor and stem cell populations demonstrate higher sensitivity to the HSP90 inhibitor PU-H71
    Meeting Abstract

    Zong, H. L.; Taldone, T.; Ahn, J. H.; Brennan, S.; De Leon, J. P.; Becker, M. W.; Roboz, G. J.; Chiosis, G.; Guzman, M. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Patterns of disease relapse and progression in patients with multiple myeloma after first line therapy with autologous stem cell transplantation: Implications for patient monitoring after transplantation
    Meeting Abstract

    Zamarin, D.; Bhutani, M.; Chimento, D.; Giralt, S.; Lendvai, N.; Landau, H.; Lesokhin, A.; Chung, D.; Babu, D.; Hassoun, H.
    Blood (2011)

    Fulltext@MSK | Save
  • Dysregulated expression of HSP70 isoforms in acute myelogenous leukemia (AML)
    Meeting Abstract

    Sharma, K. K.; Rico, J. F.; Hassane, D. C.; Chiosis, G.; Guzman, M. L.
    Blood (2011)

    Fulltext@MSK | Save
  • A cytotoxic human monoclonal antibody recognizing cell surface WT1 peptide/HLA-A2 complexes
    Meeting Abstract

    Scheinberg, D. A.; Dao, T.; Yan, S. ; Zhou, L.; Korontsvit, T.; Zakhaleva, V.; Curcio, M.; Liu, C.
    Blood (2011)

    Fulltext@MSK | Save